Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Deals > All

East Germany North Germany South Germany West Germany Austria Germany Switzerland [ # 12 & 35 ]

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 4133 | Ordered by Date (descending)
1 2 3 ... 40 41 42

Deal: Collaboration or Financing	Date
OpGen–SEVERAL: investment, 201503–201505 IPO $17.1m+$2.565m with 2.85m+427.5k units consisting of 1 share + 1 warrant at $6/unit	2015-03-03
Aquila Biolabs–SEVERAL: investment, 2015 seed financing round 7-digit €	2015-01-01
Atomwise–SEVERAL: investment, 2015 seed financing round incl Y Combinator + Khosla Ventures + DJF	2015-01-01
Kurma–SEVERAL: investment, 2015 final closing €35m of Kurma Diagnostics Fund (KDx)	2015-01-01
Tricares–CapDecisif: investment, 2015 seed financing round incl investor CapDecisif Management	2015-01-01
Tricares–Crédit Mutuel-CIC: investment, 2015 seed financing round incl investor CM-CIC Innovation	2015-01-01
Tricares–GO Capital: investment, 2015 seed financing round incl investor GO Capital	2015-01-01
Tricares–SEVERAL: investment, 2015 seed financing round with CapDecisif + GO Capital + CM-CIC Innovation	2015-01-01
i3 Membrane–SEVERAL: investment, 201408 investment by HTGF + Innovationsstarter Fonds Hamburg	2014-08-01
Synaffix–Aravis: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital	2014-02-18
Synaffix–BioGeneration Ventures: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital	2014-02-18
Synaffix–BOM Capital: investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital	2014-02-18
Synaffix–Merck (DE): investment, 201402 financing round Series A incl Aravis + BioGeneration Ventures + MS Ventures + BOM Capital	2014-02-18
ArchiMed–SEVERAL: investment, 2014 closing of MED I Fund at €150m	2014-01-01
Electrochaea–SEVERAL: investment, 2014 financing round Series A	2014-01-01
Mestex–SEVERAL: investment, 2014 1st financing round	2014-01-01
Rebiotix–SEVERAL: investment, 2014 financing round Series B $25m	2014-01-01
Sirion Biotech–LaVoieHealthScience: public relations, 2014– supply service US PR/IR	2014-01-01
Sirion Biotech–Cevec: cell lines, 201312– license €na to CAP cell lines for expression of AAV vectors	2013-12-19
Mission Therapeutics–Roche: investment, 201311 financing round Series B totalling £20m incl existing investor Roche Venture Fund	2013-11-18
BioNTech–MAB Discovery: antibody technology, 2013– collab mAb generation using technology of MAB Discovery	2013-01-01
PlasmidFactory–Sirion Biotech: gene delivery technology, 201212– collab pronotion of AAV vectors for preclinical ersearch	2012-12-04
Vivacta–Novartis: investment, 2012 acquisition by Novartis	2012-01-01
AVISO GmbH–ALS Automated Lab Solutions: investment, 2011 newly found ALS acquires all assets of AVISO keeping core team intact	2011-01-01
Boehringer–Minapharm: rec protein production technology, 2011– collab Boehringer early adopter of ProBioGen’s GlymaxX afucosylation technology	2011-01-01
Meiji Seika Kaisha–Newron: safinamide, 2011– license to develop + manufacture + commercialise safinamide in Asia to Meiji Seika Pharma	2011-01-01
Rebiotix–SEVERAL: investment, 2011 seed financing round $5m	2011-01-01
FoldRx–Pfizer: investment, 202009– acquisition $53m by Pfizer	2010-09-01
China National Nuclear–ITM: radiopharmaceuticals, 2010– collab strategic partnership with CIRC in China	2010-01-01
KLIFO–PERSON: investment, 2008 acquisition of KLIFO A/S by Alejandra Mørk who joins as CEO	2008-01-01
Hoechst–Clariant: investment, 1997 acquisition of Hoechst Speciality Chemical Business by Clariant	1997-01-01
Mind NRG–Minerva Neurosciences: investment, before 202008 acquisition of Mind NRG (CH) by Minerva Neurosciences
OTHER–Novartis: investment, 201401 acquisition of biologics manufacturing faciltiy in Longmont CO by AveXis

1 2 3 ... 40 41 42

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)